Olema Oncology, a clinical-stage biopharmaceutical company focused on breast cancer therapies, announced its participation in several investor conferences throughout November 2026, including events in Boston, New York, and London. These presentations will feature fireside chats and will be available via live webcast on Olema's investor relations website. The company is advancing its lead drug candidate, palazestrant, currently in Phase 3 trials, and is also developing a Phase 1 candidate, OP-3136. These events provide Olema an opportunity to update investors on its clinical progress and strategic direction.
Olema Oncology's upcoming investor conference participation is noted here with Pluang's health sector market data as of Nov 03, 2026 04:11 WIB: Out of 150 priced health-sector US stocks on Pluang, 48 rose and 100 fell today. Notable movers include HIMS at USD 25.22 with a 1-day change of -8.89%, TVTX at USD 46.00 down 8.71%, and NTRA at USD 379.01 down 8.49%.
The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...
Exosens disclosed its monthly update on the total number of shares and voting rights in its share capital as of October 31, 2026. The company has 50,936,749 shares outstanding, with 59,162,039 exercisable voting rights after deducting treasury shares...
Exosens has released its monthly update on the total number of shares and voting rights composing its capital as of October 31, 2026. The company reports 50,936,749 total shares and 59,425,768 theoretical voting rights, with 59,162,039 exercisable vo...
Cabot Corporation announced Q4 2026 diluted EPS of $1.25 and adjusted EPS of $1.61, with full-year diluted EPS at $4.02 and adjusted EPS at $6.42. The company reported strong segment EBITs, including $235 million from Performance Chemicals and $379 m...
Midland States Bancorp, Inc. announced a quarterly cash dividend of $0.33 per common share payable on November 20, 2026, to shareholders of record by November 13, 2026. Additionally, a cash dividend of $0.4844 per share was declared for its 7.75% Fix...
